Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             123 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of linear immunoglobulin A bullous dermatosis in a patient exposed to sun and an analgesic Pellicano, Riccardo
2009
31 Supplement 3 p. 1987-1990
4 p.
artikel
2 A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: A prospective cohort study Li, Xiayu
2009
31 Supplement 3 p. 741-750
10 p.
artikel
3 A multicenter, randomized, double-blind, placebo- controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain Southworth, Stephen
2009
31 Supplement 3 p. 1922-1935
14 p.
artikel
4 An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists van Roon, Eric N.
2009
31 Supplement 3 p. 1737-1746
10 p.
artikel
5 An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus Loomba-Albrecht, Lindsey A.
2009
31 Supplement 3 p. 816-820
5 p.
artikel
6 Anthracycline- and/or taxane-resistant breast cancer: Results of a literature review to determine the clinical challenges and current treatment trends Moreno-Aspitia, Alvaro
2009
31 Supplement 3 p. 1619-1640
22 p.
artikel
7 A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: A randomized, double-blind, two-period crossover study in healthy volunteers Darwish, Mona
2009
31 Supplement 3 p. 108-114
7 p.
artikel
8 A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: Evaluation of pain and somatic pain thresholds Affaitati, Giannapia
2009
31 Supplement 3 p. 705-720
16 p.
artikel
9 A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally Veldhorst-Janssen, Nicole M.L.
2009
31 Supplement 3 p. 2954-2987
34 p.
artikel
10 A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis Bachert, Claus
2009
31 Supplement 3 p. 921-944
24 p.
artikel
11 A review of three stand-alone topical thrombins for surgical hemostasis Cheng, Christine M.
2009
31 Supplement 3 p. 32-41
10 p.
artikel
12 Arterial wave reflection during antihypertensive therapy with barnidipine: A 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension Palombo, Carlo
2009
31 Supplement 3 p. 2873-2885
13 p.
artikel
13 A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins Ofosu, Frederick A.
2009
31 Supplement 3 p. 679-691
13 p.
artikel
14 A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions Elshafeey, Ahmed H.
2009
31 Supplement 3 p. 600-608
9 p.
artikel
15 A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions Marcelín-Jiménez, Gabriel
2009
31 Supplement 3 p. 2002-2011
10 p.
artikel
16 Assessment of the bioequivalence of brand and biogeneric formulations of abciximab for the treatment of acute coronary syndrome: A prospective, open-label, randomized, controlled study in Korean patients Choi, Dong-Hyun
2009
31 Supplement 3 p. 1804-1811
8 p.
artikel
17 Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study Karpecki, Paul
2009
31 Supplement 3 p. 514-526
13 p.
artikel
18 Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers Rhim, Si-Youn
2009
31 Supplement 3 p. 1037-1045
9 p.
artikel
19 Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: An open-label, randomized, two-period crossover comparison in healthy mexican volunteers Galan-Herrera, Juan Francisco
2009
31 Supplement 3 p. 1796-1803
8 p.
artikel
20 Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): Single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects Palma-Aguirre, Jose Antonio
2009
31 Supplement 3 p. 399-410
12 p.
artikel
21 Bioequivalence of a single 10-mg dose of finasteride 5-mg oral disintegrating tablets and standard tablets in healthy adult male Han Chinese volunteers: A randomized sequence, open-label, two-way crossover study Chen, Li
2009
31 Supplement 3 p. 2242-2248
7 p.
artikel
22 Bioequivalence of generic and branded subcutaneous enoxaparin: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects Feng, Limin
2009
31 Supplement 3 p. 1559-1567
9 p.
artikel
23 Bioequivalence of single 100-mg doses of two oral formulations of topiramate: An open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers Piñeyro-López, Alfredo
2009
31 Supplement 3 p. 411-417
7 p.
artikel
24 Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: Results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers Maanen, Rob van
2009
31 Supplement 3 p. 1244-1255
12 p.
artikel
25 Case study on monoclonal gammopathy of undetermined significance/multiple myeloma Cappellini, Maria Domenica
2009
31 Supplement 3 p. S181-
1 p.
artikel
26 Celecoxib in the treatment of primary dysmenorrhea: Results from two randomized, double-blind, active- and placebo-controlled, crossover studies Daniels, Stephen
2009
31 Supplement 3 p. 1192-1208
17 p.
artikel
27 Certolizumab pegol for the management of Crohn's disease in adults Rivkin, Anastasia
2009
31 Supplement 3 p. 1158-1176
19 p.
artikel
28 Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan Hsiao, Fei-Yuan
2009
31 Supplement 3 p. 2618-2627
10 p.
artikel
29 Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience Sakoulas, George
2009
31 Supplement 3 p. 1936-1945
10 p.
artikel
30 Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus Sonnett, Travis E.
2009
31 Supplement 3 p. 245-259
15 p.
artikel
31 Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: An 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients Kim, Jinhyun
2009
31 Supplement 3 p. 2860-2872
13 p.
artikel
32 Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: An open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers Lee, SeungHwan
2009
31 Supplement 3 p. 3000-3008
9 p.
artikel
33 Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial Heller, Simon
2009
31 Supplement 3 p. 2086-2097
12 p.
artikel
34 Comparison of the effect of antibiotic treatment on the possibility of diagnosing invasive pneumococcal disease by culture or molecular methods: A prospective, observational study of children and adolescents with proven pneumococcal infection Resti, Massimo
2009
31 Supplement 3 p. 1266-1273
8 p.
artikel
35 Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: A phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study Ste-Marie, Louis-Georges
2009
31 Supplement 3 p. 272-285
14 p.
artikel
36 Comparison of the pharmacokinetics of sulfamethoxazole in male chinese volunteers at low altitude and acute exposure to high altitude versus subjects living chronically at high altitude: An open-label, controlled, prospective study Li, Xiang-Yang
2009
31 Supplement 3 p. 2744-2754
11 p.
artikel
37 Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/Ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers Kim, Tae-Eun
2009
31 Supplement 3 p. 2249-2257
9 p.
artikel
38 Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: Results of a markov model analysis Fajutrao, Liberty
2009
31 Supplement 3 p. 1456-1468
13 p.
artikel
39 Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan Miyazaki, Yoshiko
2009
31 Supplement 3 p. 2433-2441
9 p.
artikel
40 Current and emerging therapies for acute myeloid leukemia Robak, Tadeusz
2009
31 Supplement 3 p. 2349-2370
22 p.
artikel
41 Degarelix: A gonadotropin-releasing hormone antagonist for the management of prostate cancer Steinberg, Michael
2009
31 Supplement 3 p. 2312-2331
20 p.
artikel
42 Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies Tourian, Karen A.
2009
31 Supplement 3 p. 1405-1423
19 p.
artikel
43 Dose accuracy and durability of the NovoPen® 4 insulin delivery device before and after simulation of 5 years of use and under various stress conditions Kristensen, Carsten M.
2009
31 Supplement 3 p. 2819-2823
5 p.
artikel
44 Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis Caruso, Angelo
2009
31 Supplement 3 p. 580-584
5 p.
artikel
45 Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: Results from an analysis of data from a US claims database Pelletier, Elise M.
2009
31 Supplement 3 p. 2653-2664
12 p.
artikel
46 Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: A retrospective chart review and patient questionnaire Wedlake, Linda
2009
31 Supplement 3 p. 2549-2558
10 p.
artikel
47 Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: Systematic review and meta-analyses Shah, Vibhuti
2009
31 Supplement 3 p. S104-S151
48 p.
artikel
48 Effect of multidrug resistance gene-1 (ABCB1) polymorphisms on the single-dose pharmacokinetics of cloxacillin in healthy adult Chinese men Yin, Ophelia Q.P.
2009
31 Supplement 3 p. 999-1006
8 p.
artikel
49 Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: A single-center, open-label, prospective, observational study Deal, Eli N.
2009
31 Supplement 3 p. 299-310
12 p.
artikel
50 Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: A single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial Akural, Ethem I.
2009
31 Supplement 3 p. 560-568
9 p.
artikel
51 Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies Williams, Daphne D.
2009
31 Supplement 3 p. 764-776
13 p.
artikel
52 Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: A randomized, double-blind, four-arm trial in adults undergoing abdominal surgery Oifa, Stanislav
2009
31 Supplement 3 p. 527-541
15 p.
artikel
53 Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: A phase I, randomized, open-label, crossover study in healthy volunteers Krishna, Gopal
2009
31 Supplement 3 p. 286-298
13 p.
artikel
54 Effects of pitavastatin on cerebral blood flow Horimoto, Yoshihiko
2009
31 Supplement 3 p. 575-579
5 p.
artikel
55 Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder De Candia, Maria Pia
2009
31 Supplement 3 p. 2851-2859
9 p.
artikel
56 Efficacy and tolerability of intranasal fentanyl spray 50 to 200 μg for breakthrough pain in patients with cancer: A phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period Kress, Hans Georg
2009
31 Supplement 3 p. 1177-1191
15 p.
artikel
57 Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension Germino, F. Wilford
2009
31 Supplement 3 p. 1946-1956
11 p.
artikel
58 Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study Emkey, Ronald
2009
31 Supplement 3 p. 751-761
11 p.
artikel
59 Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: A post hoc analysis of three studies of children aged 2 to 6 years Block, Stan L.
2009
31 Supplement 3 p. 2140-2147
8 p.
artikel
60 Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: A meta-analysis of randomized clinical trials Machado, Márcio
2009
31 Supplement 3 p. 962-979
18 p.
artikel
61 Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: A 3-month, randomized, double-blind, placebo-controlled trial Ogrendik, Mesut
2009
31 Supplement 3 p. 1754-1764
11 p.
artikel
62 Estimated annual direct expenditures in the united states as a result of inappropriate hypertension treatment according to national treatment guidelines Balu, Sanjeev
2009
31 Supplement 3 p. 1581-1594
14 p.
artikel
63 Evaluation of the dose—response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension Puig, Juan G.
2009
31 Supplement 3 p. 2839-2850
12 p.
artikel
64 Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection Carrascosa, Miguel F.
2009
31 Supplement 3 p. 1014-1019
6 p.
artikel
65 First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: Results of a retrospective claims review Sung, Si-Kyung
2009
31 Supplement 3 p. 1309-1320
12 p.
artikel
66 Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis Toulis, Konstantinos A.
2009
31 Supplement 3 p. 221-235
15 p.
artikel
67 High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: A retrospective chart review Mahtani, Reshma L.
2009
31 Supplement 3 p. 2371-2378
8 p.
artikel
68 Impact of long-term statin treatment on coronary plaque composition at angiographically severe lesions: A nonrandomized study of the history of long-term statin treatment before coronary angioplasty Miyagi, Motohiro
2009
31 Supplement 3 p. 64-73
10 p.
artikel
69 Inadequate pain management during routine childhood immunizations: The nerve of it Taddio, Anna
2009
31 Supplement 3 p. S152-S167
16 p.
artikel
70 Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: A single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea Kim, Bo-Hyung
2009
31 Supplement 3 p. 1234-1243
10 p.
artikel
71 Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: A retrospective review Snider, Melissa
2009
31 Supplement 3 p. 1209-1218
10 p.
artikel
72 In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals Eagye, Kathryn J.
2009
31 Supplement 3 p. 2678-2688
11 p.
artikel
73 Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children Singh-Franco, Devada
2009
31 Supplement 3 p. 1664-1687
24 p.
artikel
74 Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: A 4-week, nonrandomized, open-label, uncontrolled observational study Mercadante, Sebastiano
2009
31 Supplement 3 p. 2134-2138
5 p.
artikel
75 Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: A multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial Orlikowski, David
2009
31 Supplement 3 p. 1765-1773
9 p.
artikel
76 Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia Sorensen, Sonja V.
2009
31 Supplement 3 p. 862-879
18 p.
artikel
77 Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: A new simulation model De Wals, Philippe
2009
31 Supplement 3 p. 2152-2169
18 p.
artikel
78 Neutralization of α2-antiplasmin by microplasmin: A randomized, double-blind, placebo-controlled, ascending-dose study in healthy male volunteers Pakola, Steve
2009
31 Supplement 3 p. 1688-1706
19 p.
artikel
79 Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: A single- and multiple-dose, open-label pharmacokinetic study in Chinese patients Zhou, Li
2009
31 Supplement 3 p. 1568-1575
8 p.
artikel
80 N-of-1 double-blind, randomized controlled trial of tramadol to treat chronic cough Louly, Priscila Gebrim
2009
31 Supplement 3 p. 1007-1013
7 p.
artikel
81 Once-monthly oral ibandronate in postmenopausal osteoporosis: Translation and updated review Rossini, Maurizio
2009
31 Supplement 3 p. 1497-1510
14 p.
artikel
82 Pharmacokinetic and bioequivalence comparison between orally disintegrating and conventional tablet formulations of flurbiprofen: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy chinese male volunteers Liu, Yan-Mei
2009
31 Supplement 3 p. 1787-1795
9 p.
artikel
83 Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: A single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers Kim, Bo-Hyung
2009
31 Supplement 3 p. 2755-2764
10 p.
artikel
84 Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products Daley-Yates, Peter T.
2009
31 Supplement 3 p. 370-385
16 p.
artikel
85 Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: A single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects Nunes, Teresa
2009
31 Supplement 3 p. 2258-2271
14 p.
artikel
86 Pharmacokinetics and tolerability of single escalating doses of fampridine sustained-release tablets in patients with multiple sclerosis: A phase I–II, open-label trial Vollmer, Timothy
2009
31 Supplement 3 p. 2206-2214
9 p.
artikel
87 Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation Petrides, Petro E.
2009
31 Supplement 3 p. 386-398
13 p.
artikel
88 Pharmacokinetics of a Once-Daily extended-release formulation of pramipexole in healthy male volunteers: Three studies Jenner, Peter
2009
31 Supplement 3 p. 2698-2711
14 p.
artikel
89 Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: An open-label, single-dose, three-period crossover study in healthy volunteers Nave, Ruediger
2009
31 Supplement 3 p. 2988-2999
12 p.
artikel
90 Pharmacokinetics of conivaptan hydrochloride, a vasopressin V1A/V2-receptor antagonist, in patients with euvolemic or hypervolemic hyponatremia and with or without congestive heart failure from a prospective, 4-day open-label study Mao, Zhongping Lily
2009
31 Supplement 3 p. 1542-1550
9 p.
artikel
91 Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers Blight, Andrew R.
2009
31 Supplement 3 p. 328-335
8 p.
artikel
92 Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: A randomized, open-label, single- and multiple-dose study Zhao, Rui-ke
2009
31 Supplement 3 p. 1022-1036
15 p.
artikel
93 Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study Faessel, Helene
2009
31 Supplement 3 p. 177-189
13 p.
artikel
94 Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: An open-label, randomized-sequence, three-treatment, three-way crossover study Cho, Sang-Heon
2009
31 Supplement 3 p. 1046-1053
8 p.
artikel
95 Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: A randomized, placebo-controlled, single-blind, dose-escalation, crossover study Malloy, Jaret
2009
31 Supplement 3 p. 806-815
10 p.
artikel
96 Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: Systematic review of randomized controlled trials and quasi-randomized controlled trials Taddio, Anna
2009
31 Supplement 3 p. S48-S76
29 p.
artikel
97 Poster abstracts 2009
31 Supplement 3 p. S29-S45
17 p.
artikel
98 Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers Kim, Kyu-pyo
2009
31 Supplement 3 p. 2098-2106
9 p.
artikel
99 Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: A retrospective cohort study Yang, Yi
2009
31 Supplement 3 p. 2178-2188
11 p.
artikel
100 Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia Kim, Aryun
2009
31 Supplement 3 p. 2765-2778
14 p.
artikel
101 Psychological interventions for reducing pain and distress during routine childhood immunizations: A systematic review Chambers, Christine T.
2009
31 Supplement 3 p. S77-S103
27 p.
artikel
102 Relative bioavailability of generic and branded 250-mg and 500-mg oral chlorphenesin carbamate tablets in healthy Korean volunteers: A single-dose, randomized-sequence, open-label, two-period crossover trial Yu, Ji-young
2009
31 Supplement 3 p. 2735-2743
9 p.
artikel
103 Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States Esposito, Dominick
2009
31 Supplement 3 p. 644-656
13 p.
artikel
104 Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting McAdam-Marx, Carrie
2009
31 Supplement 3 p. 1116-1123
8 p.
artikel
105 Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions Spínola, Ana Cristina Franco
2009
31 Supplement 3 p. 1992-2001
10 p.
artikel
106 Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication Rofail, Diana
2009
31 Supplement 3 p. 1488-1496
9 p.
artikel
107 Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy Niwa, Takashi
2009
31 Supplement 3 p. 2126-2133
8 p.
artikel
108 Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: A randomized, double-blind, crossover study in healthy adult subjects Datto, Catherine
2009
31 Supplement 3 p. 492-502
11 p.
artikel
109 Severe insulin allergy after percutaneous transluminal coronary angioplasty Wang, Chun
2009
31 Supplement 3 p. 569-574
6 p.
artikel
110 Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta Comi, Giancarlo
2009
31 Supplement 3 p. 1142-1157
16 p.
artikel
111 Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: A prospective, randomized, double-masked, active-controlled, three-period crossover pilot study Sonty, Sriram
2009
31 Supplement 3 p. 2063-2071
9 p.
artikel
112 Silodosin: A selective α1A-adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia Schilit, Sara
2009
31 Supplement 3 p. 2489-2502
14 p.
artikel
113 Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-Release 10-mg tablets in patients with multiple sclerosis: A 2-week, open-label, follow-up study Vollmer, Timothy
2009
31 Supplement 3 p. 2215-2223
9 p.
artikel
114 Tapentadol hydrochloride: A centrally acting oral analgesic Wade, William E.
2009
31 Supplement 3 p. 2804-2818
15 p.
artikel
115 The effect of pramipexole on mood and motivational symptoms in parkinson's disease: A meta-analysis of placebo-controlled studies Leentjens, Albert F.G.
2009
31 Supplement 3 p. 89-98
10 p.
artikel
116 The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: An open-label, one-sequence, three-period, three-treatment crossover study Shin, Kwang-Hee
2009
31 Supplement 3 p. 3009-3020
12 p.
artikel
117 The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: A retrospective cohort study using a US health insurance database Ziyadeh, Najat
2009
31 Supplement 3 p. 2665-2677
13 p.
artikel
118 Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children Abelson, Mark B.
2009
31 Supplement 3 p. 1908-1921
14 p.
artikel
119 Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review Hung, Yuan-Pin
2009
31 Supplement 3 p. 1977-1986
10 p.
artikel
120 Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs Dodick, David W.
2009
31 Supplement 3 p. 542-559
18 p.
artikel
121 Treatment of depression in the elderly: A review of the recent literature on the efficacy of single- versus dual-action antidepressants Mukai, Yuki
2009
31 Supplement 3 p. 945-961
17 p.
artikel
122 Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin Kelesidis, Theodoros
2009
31 Supplement 3 p. 2894-2899
6 p.
artikel
123 Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims McHorney, Colleen A.
2009
31 Supplement 3 p. 2584-2607
24 p.
artikel
                             123 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland